News

Asembia and Outcomes Team Up for Enhanced Patient Experience

Asembia and Outcomes Team Up for Enhanced Patient Experience

Asembia and Outcomes Join Forces

Asembia, a leader in specialty pharmaceutical services, has announced an exciting collaboration with Outcomes, a premier clinical engagement platform. This partnership aims to enhance prescription support and improve patient access to therapies, creating significant advancements in patient care.

Transforming Patient Engagement

The integration of Asembia's industry-leading HUB services into the Outcomes platform marks a transformative shift in how patient engagement is approached. By embedding these services directly into pharmacy workflows, the partnership aims to streamline patient interactions at pivotal moments during the prescription journey.

Improving Care Access

This collaboration is designed to tackle the critical issue of prescription abandonment. Traditionally, access to patient services has relied heavily on provider referrals. However, with the new capabilities of the Outcomes platform, patients can proactively connect with Asembia's patient services team for assistance in accessing their prescribed therapies.

Enhancing Continuity of Care

By enabling earlier interventions, the partnership enhances the continuity of care offered to patients. A personalized patient experience is now more achievable than ever, thanks to this proactive approach to patient support.

Leadership Insights

Thomas Cohn, Asembia's Chief Strategy Officer, expressed enthusiasm about the collaboration, stating, "We are thrilled to partner with Outcomes to enhance our patient engagement efforts. This collaboration allows us to connect with patients who need our support directly and efficiently ensuring they receive the therapies they need without unnecessary delays. Together, we're creating a seamless, supportive experience that puts patients first."

Broader Impact on Healthcare

The Outcomes platform is pivotal in creating a robust network of pharmacies that connect with over 100 million lives. This network facilitates the delivery of important digital messaging streams, including refill reminders and order-ready alerts, which are essential in promoting timely access to therapies.

Empowering Communities

Brent Stutz, Chief Strategy Officer of Outcomes, remarked on the significance of this partnership, stating, "Our partners leverage our pharmacy network and robust technology platform to facilitate connections between patients and critical medication services. That's what makes this partnership with Asembia so exciting — it's a meaningful step forward in improving access and outcomes for the communities we serve." This collaborative effort not only enhances pharmacy services but also promises to significantly impact patient health journeys positively.

Advantages of Integrated Services

By consolidating access services and patient engagement within a single platform, Asembia and Outcomes are not only accelerating therapy initiation and improving adherence but are also paving the way for superior healthcare outcomes across the spectrum. Such integration represents a forward-thinking approach to patient care that addresses existing gaps in healthcare services.

About Asembia

Asembia is a prominent provider of solutions for the specialty pharmaceutical sector. Through its patient support division, ASPN, Asembia delivers innovative services that empower patients to overcome barriers to access their necessary therapies and maintain their treatment regimens.

Frequently Asked Questions

What is the purpose of the Asembia and Outcomes partnership?

The partnership aims to enhance patient engagement and improve access to therapies through integrated pharmacy support services.

How will patient access to therapies improve?

With the collaboration, patients can reach out directly for assistance, facilitating timely interventions and support during their prescription journey.

What benefits does the Outcomes platform provide?

The Outcomes platform connects pharmacies to a large network, facilitating important communications like refill reminders and medication alerts.

Who are the key leaders involved in this partnership?

Thomas Cohn from Asembia and Brent Stutz from Outcomes are the Chief Strategy Officers advocating for this collaboration.

How does Asembia support its patients?

Asembia, through its ASPN division, provides innovative services aimed at overcoming patient access barriers and ensuring adherence to prescribed therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Excellence in Actuarial Science: SCOR Awards 2025

Updated Category News Views 116

SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...

Continue Reading
Gentex Corporation Announces Earnings Release Date for 2024

Updated Category News Views 190

Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...

Continue Reading
Lockton's Strategic Move in Saudi Arabia with New Leadership

Updated Category News Views 197

Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...

Continue Reading
Revolutionizing Defense: AMIAD and Dassault Aviation Unite

Updated Category News Views 158

Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....

Continue Reading
Innovative Trauma Solutions by Globus Medical Enhance Patient Care

Updated Category News Views 133

Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...

Continue Reading